Advertisement

Topics

Merck KGaA backs annual forecast on receding currency headwinds, as Q1 sales growth led by Bavencio, Mavenclad https://www.firstwordpharma.com/node/1640758 

07:40 EDT 14 May 2019 | FirstWord Pharma

Merck KGaA backs annual forecast on receding currency headwinds, as Q1 sales growth led by Bavencio, Mavenclad https://www.firstwordpharma.com/node/1640758 

Original Article: Merck KGaA backs annual forecast on receding currency headwinds, as Q1 sales growth led by Bavencio, Mavenclad https://www.firstwordpharma.com/node/1640758 

NEXT ARTICLE

More From BioPortfolio on "Merck KGaA backs annual forecast on receding currency headwinds, as Q1 sales growth led by Bavencio, Mavenclad https://www.firstwordpharma.com/node/1640758 "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...